Stay updated on Risankizumab in PsA Patients: Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated to v3.6.5, replacing the previous v3.6.4. This change reflects a deployment update to the page rather than modification to study data.SummaryDifference0.0%

- Check13 days agoChange DetectedThe Ukraine site entry was updated from Zaporizhzhia to Zaporizhzhya in the locations list, reflecting a transliteration/name update for the city.SummaryDifference0.0%

- Check20 days agoChange DetectedThe footer revision changed from Revision: v3.6.3 to Revision: v3.6.4. This appears to be a general site update with no change to the study details or user actions.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small update to the page's documentation/history.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a newer revision of the study documentation.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study page now displays a recruitment-closed notice and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) to guide users.SummaryDifference0.1%

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.